189 related articles for article (PubMed ID: 16003733)
21. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
[TBL] [Abstract][Full Text] [Related]
22. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
24. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
Munaut C; Noël A; Hougrand O; Foidart JM; Boniver J; Deprez M
Int J Cancer; 2003 Oct; 106(6):848-55. PubMed ID: 12918061
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
Hur JH; Park MJ; Park IC; Yi DH; Rhee CH; Hong SI; Lee SH
J Korean Med Sci; 2000 Jun; 15(3):309-14. PubMed ID: 10895974
[TBL] [Abstract][Full Text] [Related]
27. Expression of membrane-type 1 matrix metalloproteinase in coronary vessels of allotransplanted primate hearts.
Tsukioka K; Suzuki J; Kawauchi M; Wada Y; Zhang T; Nishio A; Koide N; Endoh M; Takayama K; Takamoto S; Isobe M; Amano J
J Heart Lung Transplant; 2000 Dec; 19(12):1193-8. PubMed ID: 11124489
[TBL] [Abstract][Full Text] [Related]
28. Coordinated elevation of membrane type 1-matrix metalloproteinase and matrix metalloproteinase-2 expression in rat uterus during postpartum involution.
Manase K; Endo T; Chida M; Nagasawa K; Honnma H; Yamazaki K; Kitajima Y; Goto T; Kanaya M; Hayashi T; Mitaka T; Saito T
Reprod Biol Endocrinol; 2006 Jun; 4():32. PubMed ID: 16740171
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines.
Zhang J; Jung K; Lein M; Kristiansen G; Rudolph B; Hauptmann S; Schnorr D; Loening SA; Lichtinghagen R
Prostate; 2002 Jan; 50(1):38-45. PubMed ID: 11757034
[TBL] [Abstract][Full Text] [Related]
30. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
31. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
[TBL] [Abstract][Full Text] [Related]
32. Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.
Iwasaki M; Nishikawa A; Fujimoto T; Akutagawa N; Manase K; Endo T; Yoshida K; Maekawa R; Yoshioka T; Kudo R
Gynecol Oncol; 2002 Apr; 85(1):103-7. PubMed ID: 11925127
[TBL] [Abstract][Full Text] [Related]
33. Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.
Chaffer CL; Dopheide B; McCulloch DR; Lee AB; Moseley JM; Thompson EW; Williams ED
Clin Exp Metastasis; 2005; 22(2):115-25. PubMed ID: 16086232
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of tissue inhibitor of metalloproteinases type 1 (TIMP-1) during mouse gonad development.
Guyot R; Magre S; Leduque P; Le Magueresse-Battistoni B
Dev Dyn; 2003 Jul; 227(3):357-66. PubMed ID: 12815621
[TBL] [Abstract][Full Text] [Related]
35. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is down-regulated in estrogen-deficient rat osteoblast in vivo.
Liao EY; Liao HJ; Guo LJ; Zhou HD; Wu XP; Dai RC; Luo XH
J Endocrinol Invest; 2004 Jan; 27(1):1-5. PubMed ID: 15053235
[TBL] [Abstract][Full Text] [Related]
36. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
37. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor.
Ota K; Stetler-Stevenson WG; Yang Q; Kumar A; Wada J; Kashihara N; Wallner EI; Kanwar YS
Kidney Int; 1998 Jul; 54(1):131-42. PubMed ID: 9648071
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2.
Bai S; Thummel R; Godwin AR; Nagase H; Itoh Y; Li L; Evans R; McDermott J; Seiki M; Sarras MP
Matrix Biol; 2005 Jun; 24(4):247-60. PubMed ID: 15935631
[TBL] [Abstract][Full Text] [Related]
39. [Correlation between MMP-2 activation and MT1-MMP mRNA expression in thymic epithelial tumors].
Wang Y; Ueda Y; Shimasaki M; Liu N; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):18-23. PubMed ID: 16608644
[TBL] [Abstract][Full Text] [Related]
40. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S
Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
